2025-01-012025-12-312025-12-31false06500709INTELLIGENT OMICS LIMITED2026-05-22falseiso4217:GBPxbrli:pure065007092024-12-31065007092025-12-31065007092025-01-012025-12-31065007092023-12-31065007092024-12-31065007092024-01-012024-12-3106500709bus:SmallEntities2025-01-012025-12-3106500709bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3106500709bus:FullAccounts2025-01-012025-12-3106500709bus:PrivateLimitedCompanyLtd2025-01-012025-12-3106500709core:WithinOneYear2025-12-3106500709core:AfterOneYear2025-12-3106500709core:WithinOneYear2024-12-3106500709core:AfterOneYear2024-12-3106500709core:ShareCapital2025-12-3106500709core:SharePremium2025-12-3106500709core:RevaluationReserve2025-12-3106500709core:OtherReservesSubtotal2025-12-3106500709core:RetainedEarningsAccumulatedLosses2025-12-3106500709core:ShareCapital2024-12-3106500709core:SharePremium2024-12-3106500709core:RevaluationReserve2024-12-3106500709core:OtherReservesSubtotal2024-12-3106500709core:RetainedEarningsAccumulatedLosses2024-12-3106500709core:LandBuildings2025-12-3106500709core:PlantMachinery2025-12-3106500709core:Vehicles2025-12-3106500709core:FurnitureFittings2025-12-3106500709core:OfficeEquipment2025-12-3106500709core:NetGoodwill2025-12-3106500709core:IntangibleAssetsOtherThanGoodwill2025-12-3106500709core:ListedExchangeTraded2025-12-3106500709core:UnlistedNon-exchangeTraded2025-12-3106500709core:LandBuildings2024-12-3106500709core:PlantMachinery2024-12-3106500709core:Vehicles2024-12-3106500709core:FurnitureFittings2024-12-3106500709core:OfficeEquipment2024-12-3106500709core:NetGoodwill2024-12-3106500709core:IntangibleAssetsOtherThanGoodwill2024-12-3106500709core:ListedExchangeTraded2024-12-3106500709core:UnlistedNon-exchangeTraded2024-12-3106500709core:LandBuildings2025-01-012025-12-3106500709core:PlantMachinery2025-01-012025-12-3106500709core:Vehicles2025-01-012025-12-3106500709core:FurnitureFittings2025-01-012025-12-3106500709core:OfficeEquipment2025-01-012025-12-3106500709core:NetGoodwill2025-01-012025-12-3106500709core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3106500709core:ListedExchangeTraded2025-01-012025-12-3106500709core:UnlistedNon-exchangeTraded2025-01-012025-12-3106500709core:MoreThanFiveYears2025-01-012025-12-3106500709core:Non-currentFinancialInstruments2025-12-3106500709core:Non-currentFinancialInstruments2024-12-3106500709dpl:CostSales2025-01-012025-12-3106500709dpl:DistributionCosts2025-01-012025-12-3106500709core:LandBuildings2025-01-012025-12-3106500709core:PlantMachinery2025-01-012025-12-3106500709core:Vehicles2025-01-012025-12-3106500709core:FurnitureFittings2025-01-012025-12-3106500709core:OfficeEquipment2025-01-012025-12-3106500709dpl:AdministrativeExpenses2025-01-012025-12-3106500709core:NetGoodwill2025-01-012025-12-3106500709core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3106500709dpl:GroupUndertakings2025-01-012025-12-3106500709dpl:ParticipatingInterests2025-01-012025-12-3106500709dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3106500709core:ListedExchangeTraded2025-01-012025-12-3106500709dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3106500709core:UnlistedNon-exchangeTraded2025-01-012025-12-3106500709dpl:CostSales2024-01-012024-12-3106500709dpl:DistributionCosts2024-01-012024-12-3106500709core:LandBuildings2024-01-012024-12-3106500709core:PlantMachinery2024-01-012024-12-3106500709core:Vehicles2024-01-012024-12-3106500709core:FurnitureFittings2024-01-012024-12-3106500709core:OfficeEquipment2024-01-012024-12-3106500709dpl:AdministrativeExpenses2024-01-012024-12-3106500709core:NetGoodwill2024-01-012024-12-3106500709core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106500709dpl:GroupUndertakings2024-01-012024-12-3106500709dpl:ParticipatingInterests2024-01-012024-12-3106500709dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3106500709core:ListedExchangeTraded2024-01-012024-12-3106500709dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3106500709core:UnlistedNon-exchangeTraded2024-01-012024-12-3106500709core:NetGoodwill2025-12-3106500709core:IntangibleAssetsOtherThanGoodwill2025-12-3106500709core:LandBuildings2025-12-3106500709core:PlantMachinery2025-12-3106500709core:Vehicles2025-12-3106500709core:FurnitureFittings2025-12-3106500709core:OfficeEquipment2025-12-3106500709core:AfterOneYear2025-12-3106500709core:WithinOneYear2025-12-3106500709core:ListedExchangeTraded2025-12-3106500709core:UnlistedNon-exchangeTraded2025-12-3106500709core:ShareCapital2025-12-3106500709core:SharePremium2025-12-3106500709core:RevaluationReserve2025-12-3106500709core:OtherReservesSubtotal2025-12-3106500709core:RetainedEarningsAccumulatedLosses2025-12-3106500709core:NetGoodwill2024-12-3106500709core:IntangibleAssetsOtherThanGoodwill2024-12-3106500709core:LandBuildings2024-12-3106500709core:PlantMachinery2024-12-3106500709core:Vehicles2024-12-3106500709core:FurnitureFittings2024-12-3106500709core:OfficeEquipment2024-12-3106500709core:AfterOneYear2024-12-3106500709core:WithinOneYear2024-12-3106500709core:ListedExchangeTraded2024-12-3106500709core:UnlistedNon-exchangeTraded2024-12-3106500709core:ShareCapital2024-12-3106500709core:SharePremium2024-12-3106500709core:RevaluationReserve2024-12-3106500709core:OtherReservesSubtotal2024-12-3106500709core:RetainedEarningsAccumulatedLosses2024-12-3106500709core:NetGoodwill2023-12-3106500709core:IntangibleAssetsOtherThanGoodwill2023-12-3106500709core:LandBuildings2023-12-3106500709core:PlantMachinery2023-12-3106500709core:Vehicles2023-12-3106500709core:FurnitureFittings2023-12-3106500709core:OfficeEquipment2023-12-3106500709core:AfterOneYear2023-12-3106500709core:WithinOneYear2023-12-3106500709core:ListedExchangeTraded2023-12-3106500709core:UnlistedNon-exchangeTraded2023-12-3106500709core:ShareCapital2023-12-3106500709core:SharePremium2023-12-3106500709core:RevaluationReserve2023-12-3106500709core:OtherReservesSubtotal2023-12-3106500709core:RetainedEarningsAccumulatedLosses2023-12-3106500709core:AfterOneYear2025-01-012025-12-3106500709core:WithinOneYear2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106500709core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3106500709core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3106500709core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3106500709core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3106500709core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3106500709bus:Director12025-01-012025-12-3106500709bus:Director22025-01-012025-12-3106500709bus:Director32025-01-012025-12-31

INTELLIGENT OMICS LIMITED

Registered Number
06500709
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

INTELLIGENT OMICS LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

BALL, Graham Roy, Professor
HAWORTH, Simon Nicholas, Dr
MASON, William Thomas, Dr

Registered Address

Old Flint Barn Bury Road
Barnham
Thetford
IP24 2PL

Registered Number

06500709 (England and Wales)
INTELLIGENT OMICS LIMITED
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets31,515,2141,491,018
Tangible assets46,723576
1,521,9371,491,594
Current assets
Debtors525,69370,586
Cash at bank and on hand68,4681,200
94,16171,786
Creditors amounts falling due within one year6(563,100)(512,864)
Net current assets (liabilities)(468,939)(441,078)
Total assets less current liabilities1,052,9981,050,516
Creditors amounts falling due after one year7(924,883)(935,031)
Net assets128,115115,485
Capital and reserves
Called up share capital1,2761,276
Share premium49,90049,900
Profit and loss account76,93964,309
Shareholders' funds128,115115,485
The financial statements were approved and authorised for issue by the Board of Directors on 22 May 2026, and are signed on its behalf by:
HAWORTH, Simon Nicholas, Dr
Director
Registered Company No. 06500709
INTELLIGENT OMICS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation. Costs are recognised as an intangible asset when all of the following criteria are demonstrated: - The technical feasibility of completing the work so that it will be available for use or sale. - The intention to complete the development and use or sell it. - The ability to use the development or to sell it. - How the development will generate probable future economic benefits. - The availability of adequate technical, financial and other resources to complete the development and to use or sell it. - The ability to measure reliably the expenditure attributable to the development during its development.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment50
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year55
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 January 251,491,0181,491,018
Additions258,848258,848
Disposals(234,652)(234,652)
At 31 December 251,515,2141,515,214
Net book value
At 31 December 251,515,2141,515,214
At 31 December 241,491,0181,491,018
4.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 January 2529,34329,343
Additions7,8207,820
At 31 December 2537,16337,163
Depreciation and impairment
At 01 January 2528,76728,767
Charge for year1,6731,673
At 31 December 2530,44030,440
Net book value
At 31 December 256,7236,723
At 31 December 24576576
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-14,001
Other debtors25,69356,585
Total25,69370,586
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables77,659256,686
Bank borrowings and overdrafts1,3123,087
Amounts owed to related parties57,61545,800
Taxation and social security51,35780,573
Other creditors103,51875,831
Accrued liabilities and deferred income271,63950,887
Total563,100512,864
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts-1,312
Other creditors924,883933,719
Total924,883935,031
There is a fixed and floating charge over all the company's assets, this covers all the property or undertaking of the company
8.Related party transactions
Various transactions took place with related parties during the year that were all on normal commercial terms and on an arms length basis and therefore no further disclosure is required by FRS 102 Section 1A.